SEC 13F Intelligence

Ground Swell Capital, LLC / REGN

Ground Swell Capital, LLC’s Regeneron Pharmaceuticals Position

Does Ground Swell Capital, LLC own Regeneron Pharmaceuticals (REGN)? Not currently — the last reported position was 1.0K shares worth $574,078 in Q3 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$574,078
Q3 2025
Shares
1.0K
% of Portfolio
+1.26%
Quarters Held
5
position exited

Position History REGN

Reported value by quarter
Q1 ’21: $333,000Q1 ’21Q2 ’21: $313,000Q2 ’21Q2 ’22: $362,000Q2 ’22Q3 ’22: $221,000Q3 ’22Q3 ’25: $574,078Q3 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q3 20251.0K$574,078+1.26%
Q3 2022321$221,000+0.63%
Q2 2022613$362,000+0.66%
Q2 2021561$313,000+1.49%
Q1 2021703$333,000+1.08%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Ground Swell Capital, LLC’s full portfolio or all institutional holders of REGN.